Five hundred and ninety seven Escherichia coli (E. coli) isolates were obtained from clinical specimens at the Songklanagarind Hospital in Songkhla Province, Thailand during [2003][2004][2005]. Antimicrobial susceptibilities to ten antimicrobial agents were tested by a standard disk diffusion method. The presence of class 1 integrons was based on the detection of the integrase gene (intI1) by PCR. Extended-spectrum β-lactamases (ESBLs) were detected by a combination disk method. The highest percentage of resistance was found to ciprofloxacin (40.5%), norfloxacin (39.0%), and cefuroxime (33.2%). The IntI1 was detected in 59.5% of the tested isolates. Resistance to gentamicin, cefazolin, cefuroxime, cefotaxime, ceftriaxone, norfloxacin, and ciprofloxacin was significantly higher in class 1 integron-positive isolates (p < 0.05). The most prominent resistance pattern was for norfloxacinciprofloxacin (17.7%). ESBLs were detected in 75 out of 597 (12.6%) isolates; 56/302 (18.5%) and 19/295 (6.4%) were from hospitalized and non-hospitalized patients, respectively. Seventy-five percent of ESBL-positive strains were integron-positive isolates. Imipenem and meropenem were still able to inhibit all ESBL-producing strains. The results indicated that class 1 integrons are widely prevalent among clinical isolates of resistant E. coli especially in ESBL-producers and are probably a reservoir for producing multidrug resistance and nosocomial infections in hospitals.
INTRODUCTION
Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (E. coli) is an emerging pathogen. 1) Outbreaks due to ESBL-producing organisms have been reported from hospitals all over the world. [2] [3] [4] [5] [6] It has been recognized as an important cause of nosocomial infections. 7) ESBL-producing isolates are not only resistant to β-lactams (penicillins, first-, second-, and thirdgeneration cephalosporins, and aztreonam) but also aminoglycosides, tetracyclines, chloramphenicol, trimethoprim, sulfonamides, and quinolones. In addition, many of the more recently described ESBL * To whom correspondence should be addressed: Department of Microbiology, Faculty of Science, Prince of Songkla University, 15 Karnjanavanit Road, Hat Yai, Songkhla 90112, Thailand. Tel. & Fax: +66-7444-6661; E-mail: souwalak.p@psu. ac.th genes are frequently found within integron-like structures. 3, 8, 9) Integrons appear to play an important role in the transfer of antibiotic resistance in E. coli derived from animals and humans because they can capture, integrate, and express gene cassettes encoding antibiotic resistance. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] However, there have been only a few reports on ESBL-producing bacteria isolated in Thailand. 5, [20] [21] [22] [23] Our objective for this study was to determine the prevalence of resistance factors, including the production of ESBL and the presence of class 1 integrons, in E. coli isolated from clinical specimens obtained at the Songklanagarind Hospital the major university hospital in southern Thailand. Vol. 57 (2011) lates each collected from a single patient as a clinical specimen: urine (446), blood (45), pus (40), body fluid (30), sputum (16) , and others (20) 25) All intermediate susceptible strains were considered to be resistant strains. The presence of the ESBL phenotype was initially screened using four antimicrobial disks containing CTX (30 µg), CRO (30 µg), ceftazidime (30 µg) and cefpodoxime (10 µg). The phenotypic confirmatory test used the clavulanate double-disk synergy method, was carried out with disks containing ceftazidime (30 µg) and CTX (30 µg) either alone or in combination with clavulanic acid (30/10 µg, oxoid). The results were interpreted according to CLSI. 25) Quality control was performed using E. coli ATCC 25922 and Klebsiella pneumoniae (K. pneumoniae) ATCC 700603. Detection of Class 1 Integrons --Integrons were detected using a multiplex PCR that targetted three conserved sequences of class 1 integrons including qacEΔ1 (gene encoding resistance to quaternary ammonium compounds), intI1 (integrase gene), and sul1 (sulphonamide resistance gene), as previously described. 19) Primer pairs were purchased from a commercial source (QIA-GEN Operon GmbH, Cologne, Germany). Primers, (reported from 5 to 3 ) included, GGTTCGAAT-GTCGTAACCGC and ACGCCCTTGAGCGGAA-GTATC for amplification of the intI1 gene, ATCA- Salmonella enterica serovar Typhimurium DT104, a known carrier of a class 1 integron, was used as a positive control. The PCR products were visualized by ethidium bromide staining after agarose gel electrophoresis. The prevalence of class 1 integrons was based on the presence of the intI1 gene. Statistical Analysis --The χ 2 test was used to determine any significant differences in resistance or prevalence where appropriate. Differences were considered significant at p < 0.05.
RESULTS

Prevalence of Class 1 Integrons and ESBL in E. coli
Class 1 integrons, as indicated by the presence of intI1 was detected in 355 (59.5%) E. coli clinical isolates. One hundred and sixty-six isolates (27.8%) contained all three conserved genes associated with class 1 integrons (intI1, qacEΔ1, sul1) and 214 isolates (35.8%) contained only sul1. The occurrence of a class 1 integron was similar among the isolates from hospitalized and non-hospitalized patients (60.3 and 58.6%, respectively) as shown in Table 1 .
Of the 597 isolates tested, ESBL production was demonstrated in 75 isolates (12.6%). ESBLpositive isolates were recovered from the following specimens: urine 62.7%, pus 12.0%, body fluid 9.3%, blood 8.0%, sputum 5.3%, and other tissues 2.7%. ESBL production was more prevalent in isolates from hospitalized (18.5%) compared with non-hospitalized patients (6.4%). Class 1 integrons were more frequently found among ESBL-positive (56/75, 74.7%) than among ESBL-negative (19/75, 57.3%) E. coli strains (p < 0.05). 
Antimicrobial Susceptibility
The antimicrobial susceptibility of E. coli isolates is shown in Table 2 . Overall, the highest percentage of resistance was found to CIP (40.5%), NOR (39.0%), CXM (33.2%), FAM (26.8%), GEN (20.1%), CRO (16.8%), CTX (16.2%), AMK (10.7%), MEM (0.5%), and IMP (0.3%). Resistance to all antimicrobials tested except for IMP and MEM, was significantly more common (p < 0.05) in ESBL-positive isolates than in ESBL-negative isolates.
All ESBL-producing isolates were multidrug resistant (MDR) from 3 to 8 antimicrobials, whilst only 52.5% of ESBL-negative isolates were resistant to at least one antimicrobial, and 75.5% of those resistant isolates were MDR strains (Table 3) . Table 3 provides a comparison of the resistance patterns for ESBL-positive and ESBLnegative E. coli isolates. A total of 12 different resistance patterns were observed among the 75 ESBL-producing isolates. The most frequent pattern was GEN-FAM-CXM-CTX-CRO-NOR-CIP (33.3%), followed by AMK-GEN-FAM-CXM-CTX-CRO-NOR-CIP (28.0%) and AMK-GEN-FAM-CXM-CTX-CRO (12.0%). Forty-three resistance patterns were found among the 276 drug resistant ESBL-negative isolates. The top three resistance patterns were NOR-CIP (22.5%), CXM-NOR-CIP (11.6%), and GEN-NOR-CIP and FAM (7.6%). Only five resistance patterns were common to both groups. In addition, among the ESBLnegative isolates the MDR pattern was more prevalent in the integron-positive (45.8%) compared with the integron-negative strains (31.4%, p < 0.05).
DISCUSSION
In Asia, the prevalence of ESBL-positive isolates among clinical isolates of E. coli has been shown to vary among countries. National survey data have indicated the presence of ESBLs in 5 to 8% of E. coli isolates from Korea, Japan, Malaysia and Singapore but in 12-24% in Thailand, Taiwan, the Philippines, Indonesia, Hong Kong and China. 2, 6, 7) In the present study, the prevalence of ESBL-positive isolates from various sources in a major university hospital in the south of Thailand was 12.6%. A study by Jitsurong and Yodsawat 5) documented only a 5.1% prevalence of ESBL-positive isolates from blood in the same hospital. The ESBL-positive E. coli we isolated were mainly from urine. Moor et al. 26) also found that urine was the commonest source (97%) of ESBLproducing E. coli in their study. In the major teaching hospitals in Bangkok, 30.1% of Gram-negative bacteria and 31% of E. coli were ESBL producers. 21, 23) Patients at high risk for developing colonization or infections with ESBL-producing organisms are often seriously ill patients with prolonged hospital stays and in whom invasive medical devices are present such as urinary catheters, and endotracheal tubes of central venous lines for prolonged duration. 7) We found that 74.7% of ESBL-producing E. coli was from hospitalized patients and 62.7% of these were from urine (data not shown).
It has been well documented that class 1 integrons are most commonly found in clinical isolates of Gram-negative bacteria. 27) Su et al. 28) reported the detection of three classes of integrons in 111 clinical strains of E. coli and found that 85.6 and 3.6% of the isolates carried class 1 and class 2 integrons respectively, whereas no class 3 integron was detected. Yan et al. 29) also found a high rate of class 1 integrons (76.3%) in both Gram-positive and Gram-negative bacteria while only 0.8% of class 2 integrons was detected. Integrons have been identified as a primary source of resistance genes and are claimed to be reservoirs of antimicrobial resistance genes within microbial populations. 27, 30) In this study, the class 1 integron integrase gene (intI1) was detected in 59.5% of E. coli clinical isolates which is comparable to the study in E. coli isolated from fecal specimens of non-hospitalized patients (63%) by Phongpaichit et al. 31) but much lower than that reported by Pongpech et al. 23) who detected IntI1 in 99% of the clinical and 87% of the non-clinical E. coli isolates. The result indicated that there was less selective pressure for integronpositive isolates in the southern part of Thailand than in the central part (Bangkok etc.) .
In this study, 74.7% of ESBL-positive isolates carried a class 1 integron compared to 57.3% of the ESBL-negative isolates. ESBL enzymes including TEM, SHV and CTX-M are mostly found in clinical isolates. 32) Pongpech et al. 23) found that bla TEM and bla CTX-M were predominant among ESBL producing E. coli. In Argentina, CTX-M-2 is the most frequently found ESBL among clinical isolates in Argentinean hospitals. Almost all open reading frame (orf) 513-bearing class 1 integrons are associated with bla CTX-M-2 in the Gram-negative bacterial population under study and the sequences adjacent to the bla CTX-M-2 gene are conserved in all the studied isolates. 33) Eckert et al. 34) examined the bla CTX-M genes in E. coli and K. pneumoniae by cloning, sequencing, and PCR analysis and detected a complex sul1-type integron including an orf513, that carried the bla gene together with its surrounding DNA. We found that 60% of intI1-positive isolates also contained the sul1 gene (data not shown). The ESBLencoding genes have been reported to be located on large plasmids which may also contain other resistance genes. Resistance genes can occur within related species. Novais et al. 35) reported that the spread of the CTX-M gene in enterobacterial clinical isolates in Spain was associated with Incompatibility group (Inc)N broad-host-range and Inc-FII narrow-host-range plasmids. Mshana et al. 36) also found the conjugative IncF1 plasmids carrying CTX-M-5 among E. coli ESBL producing isolates at a University hospital in Germany also had a high rate of transferable antibiotic resistances for sulphamethoxazole (61%), tetracycline (61%) and GEN (33%).
Evaluation of the antimicrobial resistance patterns of ESBL-positive isolates showed that antimicrobial agents with a high level of effectiveness were MEM and IMP, followed by AMK. Furthermore, an association between the production of ESBL and resistance to CIP and NOR was demonstrated. This association has been observed in ESBL-producing K. pneumoniae. 37, 38) All our ESBL producers were MDR from 3 to 8 antimicrobial agents. The high resistance profile of ESBLproducing E. coli to the antimicrobial agents readily available for treatment reflects the severe consequences of ESBL infection. Lee et al. 39) reported that the cost of infection caused by ESBL-producing E. coli and Klebsiella species was 1.7 times the cost of infection caused by non-ESBL producers. This study has demonstrated that class 1 integrons are widely prevalent among E. coli clinical isolates; especially among ESBL-producers and that they could be a reservoir for producing multidrug resistance and nosocomial infections in hospitals.
